<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Infect Public Health</journal-id><journal-id journal-id-type="iso-abbrev">J Infect Public Health</journal-id><journal-title-group><journal-title>Journal of Infection and Public Health</journal-title></journal-title-group><issn pub-type="ppub">1876-0341</issn><issn pub-type="epub">1876-035X</issn><publisher><publisher-name>The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7874929</article-id><article-id pub-id-type="pii">S1876-0341(21)00036-8</article-id><article-id pub-id-type="doi">10.1016/j.jiph.2020.12.037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (M<sup>pro</sup>) with pharmacokinetics and toxicological properties</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Panikar</surname><given-names>Sukanya</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Shoba</surname><given-names>Gunasekaran</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Arun</surname><given-names>Muthukrishnan</given-names></name><xref rid="aff0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Sahayarayan</surname><given-names>Jesudass Joseph</given-names></name><xref rid="aff0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Usha Raja Nanthini</surname><given-names>A.</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Chinnathambi</surname><given-names>Arunachalam</given-names></name><xref rid="aff0025" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="aut0035"><name><surname>Alharbi</surname><given-names>Sulaiman A.</given-names></name><xref rid="aff0025" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="aut0040"><name><surname>Nasif</surname><given-names>Omaima</given-names></name><xref rid="aff0030" ref-type="aff">f</xref></contrib><contrib contrib-type="author" id="aut0045"><name><surname>Kim</surname><given-names>Hak-Jae</given-names></name><xref rid="aff0035" ref-type="aff">g</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><aff id="aff0005"><label>a</label>Department of Biotechnology, Mother Teresa Women's University, Kodaikanal, Tamil Nadu, India</aff><aff id="aff0010"><label>b</label>Department of Biotechnology, Dwaraka Doss Goverdhan Doss Vaishnav College, Chennai, Tamil Nadu, India</aff><aff id="aff0015"><label>c</label>Department of Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India</aff><aff id="aff0020"><label>d</label>Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu 630 003, India</aff><aff id="aff0025"><label>e</label>Department of Botany and Microbiology, College of Science, King Saud University, PO Box-2455, Riyadh 11451, Saudi Arabia</aff><aff id="aff0030"><label>f</label>Department of Physiology, College of Medicine, King Saud University, [Medical City], King Khalid University Hospital, PO Box-2925, Riyadh 11461, Saudi Arabia</aff><aff id="aff0035"><label>g</label>Department of Clinical Pharmacology, College of Medicine, Soonchunhyang University, Cheonan, Republic of Korea</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding authors.</corresp></author-notes><pub-date pub-type="pmc-release"><day>10</day><month>2</month><year>2021</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>5</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>10</day><month>2</month><year>2021</year></pub-date><volume>14</volume><issue>5</issue><fpage>601</fpage><lpage>610</lpage><history><date date-type="received"><day>28</day><month>10</month><year>2020</year></date><date date-type="rev-recd"><day>12</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>19</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 The Authors</copyright-statement><copyright-year>2021</copyright-year><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0005"><sec><title>Background</title><p>The current health concern to the entire world is the chronic respiratory disease caused by coronavirus 2 (COVID-19). A specific treatment or proper therapy is still lacking, and the investigations from across the world for proper drug/vaccine development towards disease control are in progress. The Coronavirus replication takes place by the conversion of the polypeptide into functional protein and this occurs due to the key enzyme Main protease (M<sup>pro</sup>). Therefore, identification of natural and effective M<sup>pro</sup> inhibitors could be a safe and promising approach for COVID-19 control.</p></sec><sec><title>Methods</title><p>The present <italic>in silico</italic> study evaluates the effect of bioactive compounds found in <italic>Eucalyptus</italic> and <italic>Corymbia</italic> species essential oil on M<sup>pro</sup> by docking. Molecular docking of the major seven compounds of essential oil (citronellol, alpha-terpineol, eucalyptol, <sc>d</sc>-limonene, 3-carene, <italic>o</italic>-cymene, and alpha-pinene) with M<sup>pro</sup> was studied by AutoDock 4.2, and the properties were analysed by PreADMET and Biovia Discovery Studio visualizer.</p></sec><sec><title>Results</title><p>The calculated parameters such as binding energy, hydrophobic interactions, and hydrogen bond interactions of 6LU7 (M<sup>pro</sup>) with <italic>Eucalyptus</italic> and <italic>Corymbia</italic> volatile secondary metabolites represented its scope as an effective therapy option against covid-19. Among the docked compounds, eucalyptol shows the least binding energy without toxicity.</p></sec><sec><title>Conclusions</title><p>The outcome of this study reported that the essential oil of <italic>Eucalyptus</italic> and <italic>Corymbia</italic> species, mainly eucalyptol can be utilized as a potential inhibitor against COVID-19 and also it can be used in its treatment. Hence, further analysis was required to explore its potential application in medicine.</p></sec></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Autodock</kwd><kwd>COVID-19</kwd><kwd><italic>Eucalyptus</italic></kwd><kwd><italic>Corymbia</italic> eucalyptol</kwd><kwd>Molecular interaction analysis</kwd><kwd>M<sup>pro</sup></kwd></kwd-group></article-meta></front><body><sec id="sec0005"><title>Introduction</title><p id="par0005">Public health has always been a prime issue due to the continuous emerging of pandemics in last two decades. There were outbreaks of SARS-CoV-1, MERS-CoV, and now the current pandemic Coronavirus disease of 2019 (COVID-19) has become an extreme threat to human life, the livelihood, and also has brought about relentless social-economical along with political issues in the tainted countries [<xref rid="bib0005" ref-type="bibr">1</xref>]. The WHO has categorized COVID-19 as a pandemic [<xref rid="bib0010" ref-type="bibr">2</xref>]. The International Committee on Taxonomy of Viruses (ICTV) gave the name for this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [<xref rid="bib0015" ref-type="bibr">3</xref>]. COVID-19 causes ARDS-Acute Respiratory Distress Syndrome, a condition in which fluids get collected in the air sacs of lung and causes organ oxygen deprivation. The virus has shown similarity with Bat SARS-like coronavirus of more than 87.99% uniqueness in sequencing, and also 80.0% uniqueness of nucleotide with the original SARS epidemic virus [<xref rid="bib0020" ref-type="bibr">4</xref>,<xref rid="bib0025" ref-type="bibr">5</xref>]. It was found that genome of CoV encodes two proteins ppla and pplb which are involved in the formation of nucleoprotein, spike, and membrane while it is also involved in the replicase, and polymerase activity of viruses [<xref rid="bib0030" ref-type="bibr">6</xref>].</p><p id="par0010">The current treatments used for COVID-19 majorly include Convalescent plasma therapy which is based on the concept of passive immunity. Chenguang et al. (2020), carried out an experiment to find out if convalescent plasma transfusion can be beneficial in the cure of vitally infected patients of SARS-CoV-2 and it was found that the primary study showed positive outcome in the patient&#x02019;s medical status [<xref rid="bib0035" ref-type="bibr">7</xref>]. Protease inhibitor is commonly used for the management of HIV and this was used for the cure of COVID-19 in a preliminary study [<xref rid="bib0040" ref-type="bibr">8</xref>]. Nuceloside analogues including umifenovir, neuraminidase inhibitors, tenofovir disoproxil, remdesivir and lamivudine has been reported by Siti et al. (2020) for the antiviral treatments for human pathogenic CoVs [<xref rid="bib0045" ref-type="bibr">9</xref>]. Even though large numbers of these drugs are showing action for coronavirus in both in vitro along with in vivo, their side effects in terms of pharmacokinetic and pharmacodynamic properties are yet to be studied on animal and human trials. Moreover it will take quite a long time to give dependable and reliable treatment to patients. All of the drug options for COVID-19 are being tested from the previous pandemics treatment experience. However, each treatment options have its own advantages and limitations.</p><p id="par0015">In the course of recent years, the interest in nature origin medication has been on rise in different fields of medical treatment. In elective medicine and its medication, essential oils from medicinal plants are widely and generally utilized to treat several health ailments. The plant essential oils have been widely studied and are reported to have antiviral bioactivities [<xref rid="bib0050" ref-type="bibr">10</xref>]. Inhalation of steam with essential oil has previously showed positive impact for the treatment of respiratory difficulties and is suggested for managing bronchiolitis, communicable cold and disease, rhinosinusitis, allergies and flu asthma [<xref rid="bib0055" ref-type="bibr">11</xref>]. Among the conventional mainstream medication and medicines, the essential oil of <italic>Eucalyptus</italic> and <italic>Corymbia</italic> species has been utilized for the treatment of disorders associated with respiratory systems. Various researches on <italic>Eucalyptus</italic> species essential oil has been carried out to check the antibacterial and antiviral activity, which has shown positive results [<xref rid="bib0060" ref-type="bibr">[12]</xref>, <xref rid="bib0065" ref-type="bibr">[13]</xref>, <xref rid="bib0070" ref-type="bibr">[14]</xref>]. Few of the studies have been carried out on the antiviral activity of <italic>Eucalyptus</italic> essential oils and it has reported positive results for herpes simplex viruses and Adenovirus, mumps [<xref rid="bib0015" ref-type="bibr">3</xref>,<xref rid="bib0075" ref-type="bibr">15</xref>]. Various bioactivities shown by major compounds from both the essential oils has been detailed in <xref rid="tbl0005" ref-type="table">Table 1</xref>
.<table-wrap position="float" id="tbl0005"><label>Table 1</label><caption><p>Bioactivities of compounds.</p></caption><alt-text id="at0045">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Compounds</th><th align="left">Activity</th></tr></thead><tbody><tr><td align="left">Citronellol</td><td align="left">Antinociceptive, anti-inflammatory [<xref rid="bib0205" ref-type="bibr">41</xref>], antiviral activity [<xref rid="bib0210" ref-type="bibr">42</xref>]</td></tr><tr><td align="left">Alpha-terpineol</td><td align="left">Antimicrobial activity [<xref rid="bib0215" ref-type="bibr">43</xref>], antiviral activity [<xref rid="bib0220" ref-type="bibr">44</xref>]</td></tr><tr><td align="left"><italic>o</italic>-Cymene</td><td align="left">Anti-inflammatory activity [<xref rid="bib0225" ref-type="bibr">45</xref>], anti-influenza virus activity [<xref rid="bib0230" ref-type="bibr">46</xref>]</td></tr><tr><td align="left"><sc>d</sc>-Limonene</td><td align="left">Anti-viral activity [<xref rid="bib0235" ref-type="bibr">47</xref>]</td></tr><tr><td align="left">Eucalyptol</td><td align="left">Anti-viral activity [<xref rid="bib0240" ref-type="bibr">48</xref>], anti-inflammatory activity [<xref rid="bib0245" ref-type="bibr">49</xref>], antifungal activity [<xref rid="bib0250" ref-type="bibr">50</xref>]</td></tr><tr><td align="left">Alpha-pinene</td><td align="left">Anti-viral activity [<xref rid="bib0235" ref-type="bibr">47</xref>]</td></tr><tr><td align="left">3-Carene</td><td align="left">- No major bioactivity has been shown</td></tr></tbody></table></table-wrap></p><p id="par0020">As an initial step, it is highly desirable to screen and identify the potentiality of bioactive compounds present in oils of <italic>Eucalyptus</italic> and <italic>Corymbia</italic> against important therapeutic targets of SARS-CoV-2 with the help of molecular docking and its analysis. This will lead towards the progression of novel drug therapies for fighting COVID-19. However, selection of proper therapeutic target is highly crucial for an effective output. There are several therapeutic targets identified and reported for SARS-CoV-2, among which M<sup>pro</sup> is &#x0223c;306 aa long main enzyme responsible for coronavirus duplication and dispensatings the functional proteins from viral polypeptide [<xref rid="bib0080" ref-type="bibr">16</xref>]. M<sup>pro</sup> has also been mentioned as 3C-like protease (3CL<sup>pro</sup>) as it has the same restriction-site explicitness like picornavirus 3C protease (3C<sup>pro</sup>). The main protease (M<sup>pro</sup>) from COVID-19 was represented earlier as the latent and important target to stop the replication of CoV [<xref rid="bib0085" ref-type="bibr">17</xref>].</p><p id="par0025">The current study is an effort carried out to understand the molecular interaction with bioactive volatiles from oils of <italic>Eucalyptus</italic> and <italic>Corymbia</italic> against SARS-CoV-2 specifically targeting M<sup>pro</sup> and to predict the pharmacokinetics and toxological parameters of the volatile compounds taken for study. The findings and studies of this investigation will be useful to the general public and will give researchers and scientists to bring out the correct medication to fight against COVID-19 by focusing on Mpro.</p></sec><sec id="sec0010"><title>Materials and methodology</title><sec id="sec0015"><title>Essential oil from <italic>Eucalyptus</italic> and <italic>Corymbia</italic></title><p id="par0030">The leaves of <italic>Eucalyptus globulus</italic> and <italic>Corymbia citrodora</italic> were collected from Palani hill areas. The images of both the species are represented in <xref rid="fig0005" ref-type="fig">Fig. 1</xref>
. It was identified and authenticated at BSI Coimbatore. The oil from 4 kg of leaves was extracted by hydrodistillation method using copper distillation unit [<xref rid="bib0090" ref-type="bibr">18</xref>]. The procedure involves evaporation of essential oil by heating mixture of water and leaves followed by liquefaction of vapours in the condenser. The essential oils collected were stored at room temperature in air tight bottles.<fig id="fig0005"><label>Fig. 1</label><caption><p>(a) <italic>Eucalyptus globulus</italic> and (b) <italic>Corymbia citrodora</italic>.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1_lrg"/></fig></p></sec><sec id="sec0020"><title>Identification of metabolites of essential oil using GC&#x02013;MS</title><p id="par0035">The essential oils of <italic>E. globulus</italic> and <italic>C. citrodora</italic> were analysed using GC&#x02014;MS analysis according to the method described by Dey and Harborne (1997) with slight modifications. Agilent 7890B gas chromatography system with Agilent 5977B MS detector was employed for compound separation and identification [<xref rid="bib0095" ref-type="bibr">19</xref>]. The settings of GC: the initial temperature of oven was kept at 60 &#x000b0;C for 1 min which was raised at 10 &#x000b0;C min<sup>&#x02212;1</sup> to 180 &#x000b0;C then it kept for 1 min, and increased at 20 &#x000b0;C min<sup>&#x02212;1</sup> to 280 &#x000b0;C and maintained there for 15 min. Carrier gas namely helium was utilized with 1.0 ml min<sup>&#x02212;1</sup> flow rate. Spectrum was recorded with the scan ranges from 20 to 550 <italic>m/z</italic> at 2 scans s<sup>&#x02212;1</sup>. The compounds of essential oils were analysed based on alkane series compounds (C4&#x02013;C28) that determined by their retention time which compared with the chemical constituents grouped by the Adams table [<xref rid="bib0100" ref-type="bibr">20</xref>], and the mass spectrum which is similar with those of grouped compounds in the NIST-MS library was shown in the article [<xref rid="bib0105" ref-type="bibr">21</xref>].</p></sec><sec id="sec0025"><title>Protein preparation</title><p id="par0040">The crystallographic structure of SARS corona virus main protease (COVID-19 3CL<sup>pro</sup>/M<sup>pro</sup>) was retrieved from the structure database (PDB) and its PDB id is 6LU7-A Chain from <italic>Homo sapiens</italic> [<xref rid="bib0110" ref-type="bibr">22</xref>,<xref rid="bib0115" ref-type="bibr">23</xref>].</p></sec><sec id="sec0030"><title>Ligand preparation</title><p id="par0045">ACD/ChemSketch is a chemical structure depicting tool that allows us to draw compound structures. The SMILES format of the compounds, namely, citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene were retrieved from PubChem database. The 2D structure was generated through SMILES structure, converted to 3D structure, and 3D optimization was also carried out and saved in MDL-MOL File format and converted in to the PDB format using converter program (open babel) [<xref rid="bib0120" ref-type="bibr">24</xref>].</p></sec><sec id="sec0035"><title>PreADMET assessment of bioactive compounds</title><p id="par0050">The pharmacokinetic and toxicological properties of citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene were predicted using PreADMET server. The pharmacokinetic properties such as Caco-2 values which is an <italic>in vitro</italic> cell permeability parameter (Caco-2 cell model), human intestinal absorption (HIA value), plasma protein binding (PPB value), the blood&#x02013;brain barrier (BBB) penetration, P-glycoprotein (Pgp) binding parameter, and metabolic parameters (phase 1 and phase 2 enzymes) were carried out using ADME property prediction. In addition, the compounds were virtually screened to calculate and detect the toxicological properties such as mutagenicity, and carcinogenicity using toxicity prediction.</p></sec><sec id="sec0040"><title>Docking analysis and interpretations</title><p id="par0055">Molecular interaction analysis was carried out to understand the molecular affinity between the compounds, namely, citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene, against M<sup>pro</sup> of novel corona virus using AutoDock 4.2. To the 3D M<sup>pro</sup> structure of macromolecular structure hydrogen atoms (polar) and kollman charges were added. In the ligand preparation centre node and rotatable bonds were selected and saved in PDBQT format. In the grid preparation, active sites were selected and grids were adjusted with the spacing of 0.375 &#x000c5; and dimensions of x, y, and z-axes was set to 64 &#x000d7; 66 &#x000d7; 66 points and saved in grid parameter file (GPF) format and run. In docking process, the Lamarckian Genetic Algorithm (LGA) was selected which utilizes local minimisation that enables gene population modification to the complex structures [<xref rid="bib0125" ref-type="bibr">25</xref>]. The parameters of genetic algorithm were set to 10 runs with 150 population size; the number of evaluations was set to 25,000,000; generation numbers as 27,000 with default mutation rate (0.02) and crossover rate (0.8). Docking simulation was performed by utilizing AutoDock 4.2 version [<xref rid="bib0130" ref-type="bibr">26</xref>].</p></sec><sec id="sec0045"><title>Docking visualization</title><p id="par0060">The protein&#x02013;compound interactions such as bonded and other non-bonded energies among the citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-careneagainst M<sup>pro</sup> of novel corona virus were depicted by utilizing Biovia Discovery Studio visualizer. This software visualizes the molecular interaction such as hydrogen bond, hydrophobic interaction and van der Waals interactions.</p></sec></sec><sec id="sec0050"><title>Results</title><sec id="sec0055"><title>Identification of metabolites</title><p id="par0065">The compounds identified GC&#x02013;MS chromatograms of <italic>E. globulus</italic> and <italic>C. citrodora</italic> are represented in <xref rid="tbl0010" ref-type="table">Table 2</xref>
. Eucalyptol is the major compound (52.47%) present in <italic>E. globulus</italic>. The compound citronellol (59.95%) is the major component of <italic>C. citrodora.</italic> The following compounds citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene and 3-carene were taken for further study based upon the high percentage availability in the essential oils and also all these compounds are commonly found in both the <italic>Eucalyptus</italic> species taken for study.<table-wrap position="float" id="tbl0010"><label>Table 2</label><caption><p>Chemical composition of the essential oils (% total peak area).</p></caption><alt-text id="at0050">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Volatile compounds</th><th align="left"><italic>Eucalyptus globulus</italic></th><th align="left"><italic>Corymbia citrodora</italic></th></tr></thead><tbody><tr><td align="left">Citronellol</td><td align="left">&#x02013;</td><td align="left">59.31%</td></tr><tr><td align="left">Alpha-terpineol</td><td align="left">0.53%</td><td align="left">1.34%</td></tr><tr><td align="left"><italic>o</italic>-Cymene</td><td align="left">5.06%</td><td align="left">1.37%</td></tr><tr><td align="left"><sc>d</sc>-Limonene</td><td align="left">4.49%</td><td align="left">3.15%</td></tr><tr><td align="left">Eucalyptol</td><td align="left">52.47%</td><td align="left">13.54%</td></tr><tr><td align="left">Alpha-pinene</td><td align="left">17.00%</td><td align="left">2.21%</td></tr><tr><td align="left">3-Carene</td><td align="left">1.70%</td><td align="left">5.39%</td></tr></tbody></table></table-wrap></p></sec><sec id="sec0060"><title>Prediction of active sites in M<sup>pro</sup>-novel corona virus</title><p id="par0070">The crystal structure of M<sup>pro</sup> was uploaded in the Computed Atlas for Surface Topography of Proteins (CASTp) server to predict the active sites of protein. The following active sites were predicted from the pocket 1: THR24, THR25, THR26, LEU27, HIS41, CYS44, THR45, THR45, SER46, MET49, PRO52, TYR54, PHE140, LEU141, ASN142, GLY143, SER144, CYS145, HIS163, HIS164, MET165, GLU166, LEU167, PRO168, HIS172, ASP187, ARG188, GLN189, THR190, and GLN192.</p></sec><sec id="sec0065"><title>Drug likeliness assessment of the compounds from the essential oils</title><p id="par0075">The volatile compounds, namely, citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene from <italic>E. globulus</italic> and <italic>C. citrodora</italic> were analysed for molecular properties. All the compounds had molecular weight below 500, hydrogen bond donor &#x02264;5, hydrogen bond acceptor &#x02264;10, and logP value &#x02264;5. Hence, all compounds obey Lipinski&#x02019;s rule of 5. The PubChem id, 2D, 3D structures, Lipinski&#x02019;s rule are shown in <xref rid="tbl0015" ref-type="table">Table 3</xref>
.<table-wrap position="float" id="tbl0015"><label>Table 3</label><caption><p>Properties of COVID-19 M<sup>pro</sup> potential inhibitor compounds.</p></caption><alt-text id="at0055">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Properties</th><th align="left">Citronellol</th><th align="left">Eucalyptol</th><th align="left">Alpha-terpineol</th><th align="left"><sc>d</sc>-Limonene</th><th align="left"><italic>o</italic>-Cymene</th><th align="left">Alpha-pinene</th><th align="left">3-Carene a</th></tr></thead><tbody><tr><td align="left">Pubchem id</td><td align="left">8842</td><td align="left">2758</td><td align="left">17,100</td><td align="left">440,917</td><td align="left">10,703</td><td align="left">440,968</td><td align="left">26,049</td></tr><tr><td align="left">2D structure</td><td align="left"><inline-graphic xlink:href="fx1_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx2_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx3_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx4_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx5_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx6_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx7_lrg.gif"/></td></tr><tr><td align="left">3D structure</td><td align="left"><inline-graphic xlink:href="fx8_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx9_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx10_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx11_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx12_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx13_lrg.gif"/></td><td align="left"><inline-graphic xlink:href="fx14_lrg.gif"/></td></tr><tr><td align="left">Molecular formula</td><td align="left">C<sub>10</sub>H<sub>20</sub>O</td><td align="left">C<sub>10</sub>H<sub>18</sub>O</td><td align="left">C<sub>10</sub>H<sub>18</sub>O</td><td align="left">C<sub>10</sub>H<sub>16</sub></td><td align="left">C<sub>10</sub>H<sub>14</sub></td><td align="left">C<sub>10</sub>H<sub>16</sub></td><td align="left">C<sub>10</sub>H<sub>16</sub></td></tr><tr><td align="left">Molecular weight</td><td align="left">156.26</td><td align="left">154.25</td><td align="left">154.25</td><td align="left">136.23</td><td align="left">134.22</td><td align="left">136.23</td><td align="left">136.23</td></tr><tr><td align="left">Log P</td><td align="left">3.2</td><td align="left">2.72</td><td align="left">1.8</td><td align="left">3.4</td><td align="left">3.4</td><td align="left">3.54</td><td align="left">2.8</td></tr><tr><td align="left">Hydrogen bond donor</td><td align="left">1</td><td align="left">1</td><td align="left">1</td><td align="left">0</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left">Hydrogen bond acceptor</td><td align="left">1</td><td align="left">0</td><td align="left">1</td><td align="left">0</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr></tbody></table></table-wrap></p></sec><sec id="sec0070"><title>PreADMET assessment of compounds from <italic>Eucalyptus</italic> and <italic>Corymbia</italic> essential oil</title><p id="par0080">The absorption, metabolism and distribution parameters of citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene were assessed using the PreADMET server. The calculated pharmacokinetic parameters are summarized in <xref rid="tbl0020" ref-type="table">Table 4</xref>
. The predicted absorption values for Caco-2 cell (PCaco-2) were found to be between 4 and 70. Hence all compounds taken for analysis were moderately permeable. The compounds taken for study can be well absorbed through the intestinal cells as the predicted HIA values for all the compounds was found to be 100%. The predicted value of PPB for citronellol, alpha-terpineol, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene was 100.00%, indicating that the compounds are strongly bound chemicals, whereas cymene has 88.39% indicating it as weakly bound chemical. The ratio of C<sub>brain</sub>/C<sub>blood</sub> value for eucalyptol was found to be 1.46. All other compounds with a C<sub>brain</sub>/C<sub>blood</sub> value of greater than 2.0 indicate increase absorption of compounds to CNS, suggesting compounds ability to cross BBB. The compounds such as <sc>d</sc>-limonene, alpha-pinene and 3-carene were found as inhibitors of P<sub>gp</sub>, whereas citronellol, cymene, and eucalyptol were found to be non-inhibitors of P<sub>gp</sub>. The computed metabolism of compounds showed that citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene are inhibitors of CYP2C9. Other enzyme inhibition details (CYP_2C19, CYP_2D6, CYP_3A4) are displayed in <xref rid="tbl0015" ref-type="table">Table 3</xref>. The term &#x0201c;negative&#x0201d; suggests compounds having carcinogenic activity and term &#x0201c;positive&#x0201d; suggests absence of carcinogenic activity. It was found that although all compounds found to be mutagenic in the <italic>in silico</italic> AMES test model. Citronellol, cymene, and eucalyptol showed non-carcinogenicity in the mouse model and <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene show noncarcinogenicity in the rat model.<table-wrap position="float" id="tbl0020"><label>Table 4</label><caption><p>ADME and toxicity results of the seven compounds.</p></caption><alt-text id="at0060">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Properties</th><th align="left">Citronellol</th><th align="left">Alpha-terpineol</th><th align="left"><italic>o</italic>-Cymene</th><th align="left"><sc>d</sc>-Limonene</th><th align="left">Eucalyptol</th><th align="left">Alpha-pinene</th><th colspan="2" align="left">3-Carene</th></tr></thead><tbody><tr><td colspan="9" align="left"><bold>ADME</bold></td></tr><tr><td align="left">BBB</td><td align="left">7.09219</td><td align="left">5.5333</td><td align="left">4.96983</td><td align="left">8.27823</td><td align="left">1.46723</td><td colspan="2" align="left">5.5333</td><td align="left">5.5333</td></tr><tr><td align="left">Buffer_solubility_mg_L</td><td align="left">303.591</td><td align="left">1368.72</td><td align="left">328.927</td><td align="left">14.068</td><td align="left">1339.31</td><td colspan="2" align="left">1368.72</td><td align="left">1368.72</td></tr><tr><td align="left">Caco2</td><td align="left">8.91366</td><td align="left">23.6313</td><td align="left">23.4337</td><td align="left">23.6317</td><td align="left">21.895</td><td colspan="2" align="left">23.6322</td><td align="left">23.6313</td></tr><tr><td align="left">CYP_2C19_inhibition</td><td align="left">Inhibitor</td><td align="left">Non inhibitor</td><td align="left">Inhibitor</td><td align="left">Inhibitor</td><td align="left">Non inhibitor</td><td colspan="2" align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td></tr><tr><td align="left">CYP_2C9_inhibition</td><td align="left">Inhibitor</td><td align="left">Inhibitor</td><td align="left">Inhibitor</td><td align="left">Inhibitor</td><td align="left">Inhibitor</td><td colspan="2" align="left">Inhibitor</td><td align="left">Inhibitor</td></tr><tr><td align="left">CYP_2D6_inhibition</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td colspan="2" align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td></tr><tr><td align="left">CYP_2D6_substrate</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td colspan="2" align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td></tr><tr><td align="left">CYP_3A4_inhibition</td><td align="left">Non Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Inhibitor</td><td colspan="2" align="left">Non</td><td align="left">Non</td></tr><tr><td align="left">CYP_3A4_substrate</td><td align="left">Weakly</td><td align="left">Substrate</td><td align="left">Weakly</td><td align="left">Substrate</td><td align="left">Weakly</td><td colspan="2" align="left">Substrate</td><td align="left">Substrate</td></tr><tr><td align="left">HIA</td><td align="left">100</td><td align="left">100</td><td align="left">100</td><td align="left">100</td><td align="left">100</td><td colspan="2" align="left">100</td><td align="left">100</td></tr><tr><td align="left">Pgp_inhibition</td><td align="left">Non Inhibitor</td><td align="left">Inhibitor</td><td align="left">Non Inhibitor</td><td align="left">Inhibitor</td><td align="left">Non Inhibitor</td><td colspan="2" align="left">Inhibitor</td><td align="left">Inhibitor</td></tr><tr><td align="left">Plasma_Protein_Binding (%)</td><td align="left">100</td><td align="left">100</td><td align="left">88.39</td><td align="left">100</td><td align="left">100</td><td colspan="2" align="left">100</td><td align="left">100</td></tr><tr><td colspan="9" align="left"><bold>TOXICITY</bold></td></tr><tr><td align="left">Ames_test</td><td align="left">Mutagen</td><td align="left">Mutagen</td><td align="left">Mutagen</td><td align="left">Mutagen</td><td align="left">Mutagen</td><td align="left">Mutagen</td><td colspan="2" align="left">Mutagen</td></tr><tr><td align="left">Carcino_Mouse</td><td align="left">Positive</td><td align="left">Negative</td><td align="left">Positive</td><td align="left">Negative</td><td align="left">Positive</td><td align="left">Negative</td><td colspan="2" align="left">Negative</td></tr><tr><td align="left">Carcino_Rat</td><td align="left">Negative</td><td align="left">Negative</td><td align="left">Negative</td><td align="left">Positive</td><td align="left">Positive</td><td align="left">Positive</td><td colspan="2" align="left">Positive</td></tr></tbody></table></table-wrap></p></sec><sec id="sec0075"><title>Molecular docking analysis of compounds from <italic>Eucalyptus</italic> and <italic>Corymbia</italic> oil with M<sup>pro</sup></title><p id="par0085">The docking analysis of citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene against M<sup>pro</sup> by utilizing AutoDock software 4.2 version. The docking simulation generated 10 conformations of the protein&#x02013;compound complex which are displayed based on least binding free energy (&#x00394;G). The best conformations were chosen based on the least energy and minimal solvent accessibility. The interactions such as hydrogen, hydrophobic, and other non-bonded terms between the bioactive compounds and M<sup>pro</sup> are visualized using Biovia Discovery Studio Visualizer software. The M<sup>pro</sup> structure was represented as solid ribbon model, key residues were represented in red colour line model, and the compounds were represented in violet colour ball and stick model is shown in <xref rid="fig0010" ref-type="fig">Fig. 2</xref>
. The citronellol, eucalyptol, alpha-terpineol, <sc>d</sc>-limonene, <italic>o</italic>-cymene, alpha-pinene, and 3-carene showing hydrogen, hydrophobic, van der Waals interactions within active binding sites of M<sup>Pro</sup> are shown in <xref rid="fig0010" ref-type="fig">Fig. 2</xref>.<fig id="fig0010"><label>Fig. 2</label><caption><p>Citronellol (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sites of amino acid residues represented in red colour line model; (C) hydrogen bond (green dotted lines represents) and hydrophobic interactions (alkyl and pi-alkyl are shown in light pink colour dotted lines), van der Waals interactions (light green colour circles). Solvent accessible surfaces of the interacting residues are represented by a blue halo around the residues.</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xlink:href="gr2_lrg"/></fig></p></sec><sec id="sec0080"><title>Binding interaction of the compounds from <italic>Eucalyptus</italic> and <italic>Corymbia</italic> oil with M<sup>pro</sup></title><p id="par0090">The illustration of molecular interaction of citranellol, eucalyptol, alpha-terpineol, <sc>d</sc>-limonene, <italic>o</italic>-cymene, alpha-pinene, and 3-carene in the key residues of M<sup>pro</sup> are shown in <xref rid="tbl0025" ref-type="table">Table 5</xref>
. The docking simulation of M<sup>pro</sup> to citranellol has showed that citranellol forms two hydrogen bonds (GLU166) with M<sup>pro</sup>; five hydrophobic bonds formed with HIS41, MET165, and MET49; and seven van der Waals forces with TYR54, ASP187, HIS164, ARG188, GLN189, GLN192, and THR190, which are displayed in <xref rid="fig0015" ref-type="fig">Fig. 3</xref>
with a interaction energy of &#x02212;4.94 kcal/mol and 239.53 &#x003bc;M inhibitory constant (<xref rid="tbl0030" ref-type="table">Table 6</xref>
). The molecular interaction analysis of M<sup>pro</sup> with eucalyptol utilizes the least energy of &#x02013;5.86 kcal/mol and 50.78 &#x003bc;M inhibitory constant. The M<sup>pro</sup>&#x02013;eucalyptol conformation depicts 11 hydrophobic bonds with MET49, MET165, HIS164, ARG188, and PRO52 amino acids; one pi-sigma interaction with HIS41; and four van der Waals forces with ASP187, GLN189, TYR54, and PHE181 residues [<xref rid="fig0020" ref-type="fig">Fig. 4</xref>
] M<sup>pro</sup> docking analysis with alpha-terpineol showed two hydrogen bonds with GLU166; three hydrophobic alkyl and pi-alkyl bonds with MET49, MET165, and HIS41 residues; and five van der Waals forces with TYR54, LEU167, GLN189, ARG188, and ASP187 [<xref rid="fig0025" ref-type="fig">Fig. 5</xref>
(A)&#x02013;(C)] with a binding energy value of &#x02013;5.43 kcal/mol and 105.43 &#x003bc;M inhibitory constant. The docking study of M<sup>pro</sup> with <sc>d</sc>-limonene has utilized a energy value of &#x02013;5.18 kcal/mol and 159.51 &#x003bc;M inhibitory constant and 12 hydrophobic bonds with MET49, PRO52, TYR54, MET165, HIS41, CYS44, and ARG188 and three van der Waals interaction with HIS164, GLN189, and ASP187 residues were formed [<xref rid="fig0030" ref-type="fig">Fig. 6</xref>
(A)&#x02013;(C)]. The M<sup>pro</sup>-<italic>o</italic>-cymene complex formation utilized a energy value of &#x02013;4.99 kcal/mol and 219.4 &#x003bc;M inhibitory constant and results in seven hydrophobic bonds with MET165, MET49, HIS41 (alkyl and pi-alkyl interactions),and ASP187 (amide-pi stacked interaction) and five van der Waals interactions with PHE181, HIS164, TYR54, GLN189, and ARG188 residues shown in <xref rid="fig0035" ref-type="fig">Fig. 7</xref>
(A)&#x02013;(C). M<sup>pro</sup> with alpha-pinene utilizes a binding energy of &#x02013;5.61 kcal/mol and 77.63 &#x003bc;M inhibitory constant and showed seven hydrophobic bonds with PRO168, LEU167, and MET165 and five van der Waals interactions with GLN189, ARG188, THR190, GLU166, and GLN194 residues [<xref rid="fig0040" ref-type="fig">Fig. 8</xref>
(A)&#x02013;(C)]. Finally, docking simulation of M<sup>pro</sup> with 3-carene showed seven hydrophobic bonds with the M<sup>pro</sup> amino acids MET165, MET49, HIS41, TYR54, PRO52, and CYS44 (alkyl and pi-alkyl interactions) and five van der Waals interactions with GLN189, ARG188, ASP187, GLU166, and HIS164 with a binding energy &#x02013;5.43 kcal/mol and 103.88 &#x003bc;M inhibitory constant. <xref rid="tbl0025" ref-type="table">Table 5</xref> shows the least energy values, vdW + Hbond + desolv energy, torsional energy, intermolecular energy, electrostatic energy, unbound energy, inhibition constants, and refRMS value of compounds with M<sup>pro</sup>. All the energy values are given in Kcal/mol.<table-wrap position="float" id="tbl0025"><label>Table 5</label><caption><p>The <italic>Eucalyptus</italic> essential oil compounds interacting residues of the M<sup>pro</sup> proteins of novel corona virus are summarized with the number of hydrophobic interactions and the number of hydrogen bonds.</p></caption><alt-text id="at0065">Table 5</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Compounds from <italic>Eucalyptus</italic> essential oil</th><th colspan="4" align="left">Hydrogen bonds<hr/></th><th align="left">Hydrophobic interactions (pi alkyl; alkyl-alkyl; pi-sigma; amide-pi stacked)</th><th align="left">van der Waals interactions</th></tr><tr><th align="left"/><th colspan="2" align="left">M<sup>pro</sup><hr/></th><th align="left">Atom in bio-active compound</th><th align="left">Distance (&#x000c5;)</th><th align="left"/><th align="left"/></tr><tr><th align="left"/><th align="left">Aminoacid</th><th align="left">Atom</th><th align="left"/><th align="left"/><th align="left"/><th align="left"/></tr></thead><tbody><tr><td align="left">Citronellol</td><td align="left">GLU166</td><td align="left">O</td><td align="left">H</td><td align="left">2.14</td><td align="left">HIS41(2)</td><td align="left">TYR54</td></tr><tr><td align="left"/><td align="left">GLU166</td><td align="left">N</td><td align="left">N</td><td align="left">2.93</td><td align="left">MET165(2)</td><td align="left">ASP187</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET49(1)</td><td align="left">HIS164</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ARG188</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">GLN192</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">THR190</td></tr><tr><td align="left">Eucalyptol</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">MET49(3)</td><td align="left">TYR54</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET165(3)</td><td align="left">ASP187</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS164(1)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ARG188(1)</td><td align="left">PHE181</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">PRO52(1)</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS41(2)</td><td align="left"/></tr><tr><td align="left" valign="middle" rowspan="2">Alpha-terpineol</td><td align="left">GLU166</td><td align="left">O</td><td align="left">H</td><td align="left">2.14</td><td align="left">MET49(1)</td><td align="left">TYR54</td></tr><tr><td align="left">GLU166</td><td align="left">N</td><td align="left">N</td><td align="left">2.93</td><td align="left">MET165(1)</td><td align="left">LEU167</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS41(1)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ARG188</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ASP187</td></tr><tr><td align="left"><sc>d</sc>-Limonene</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">MET49(3)</td><td align="left">HIS164</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">PRO52(2)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">TYR54(2)</td><td align="left">ASP187</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET165(1)</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS41(2)</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">CYS44(1)</td><td align="left"/></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ARG188(1)</td><td align="left"/></tr><tr><td align="left"><italic>o</italic>-Cymene</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">MET165(3)</td><td align="left">PHE181</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET49(2)</td><td align="left">HIS164</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS41(1)</td><td align="left">TYR54</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ASP187(1)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">ARG188</td></tr><tr><td align="left">alpha-Pinene</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">PRO168(2)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">LEU167(1)</td><td align="left">ARG188</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET165(4)</td><td align="left">THR190</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">GLU166</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">GLN194</td></tr><tr><td align="left">3-Carene</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">MET165(2)</td><td align="left">GLN189</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">MET49(1)</td><td align="left">ARG188</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">HIS41(1)</td><td align="left">ASP187</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">0TYR54(1)</td><td align="left">GLU166</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">PRO52(1)</td><td align="left">HIS164</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">CYS44(1)</td><td align="left"/></tr></tbody></table></table-wrap><fig id="fig0015"><label>Fig. 3</label><caption><p>Eucalyptol (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active site amino acid residues amino acid residues represented in red colour line model; (C) hydrophobic interactions (alkyl and pi-alkyl are shown in light pink colour dotted lines; pi-sigma interactions are shown in dark purple), van der Waals interactions (light green colour circles).</p></caption><alt-text id="at0015">Fig. 3</alt-text><graphic xlink:href="gr3_lrg"/></fig><table-wrap position="float" id="tbl0030"><label>Table 6</label><caption><p>Inhibition constant, energy values of docking simulation of M<sup>pro</sup> with compounds.</p></caption><alt-text id="at0070">Table 6</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">M<sup>pro</sup> docking with compounds</th><th align="left">Inhibition constant (&#x003bc;M)</th><th align="left">Binding energy</th><th align="left">Ligand efficiency</th><th align="left">Intermolecular energy</th><th align="left">vdW + Hbond + desolv energy</th><th align="left">Electrostatic energy</th><th align="left">Torsional energy</th><th align="left">Total internal unbound</th><th align="left">refRMS</th></tr></thead><tbody><tr><td align="left">Citronellol</td><td align="center">239.53</td><td align="center">&#x02013;4.94</td><td align="center">&#x02013;0.45</td><td align="center">&#x02013;6.73</td><td align="center">&#x02013;6.63</td><td align="center">&#x02013;0.1</td><td align="center">1.79</td><td align="center">&#x02013;0.24</td><td align="center">73.29</td></tr><tr><td align="left">Eucalyptol</td><td align="center">50.78</td><td align="center">&#x02013;5.86</td><td align="center">&#x02013;0.53</td><td align="center">&#x02013;5.86</td><td align="center">&#x02013;5.86</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">73.76</td></tr><tr><td align="left">Alpha-terpineol</td><td align="center">105.14</td><td align="center">&#x02013;5.43</td><td align="center">&#x02013;0.49</td><td align="center">&#x02013;6.02</td><td align="center">&#x02013;5.95</td><td align="center">&#x02013;0.08</td><td align="center">0.6</td><td align="center">&#x02013;0.15</td><td align="center">71.16</td></tr><tr><td align="left"><sc>d</sc>-Limonene</td><td align="center">159.51</td><td align="center">&#x02013;5.18</td><td align="center">&#x02013;0.52</td><td align="center">&#x02013;5.48</td><td align="center">&#x02013;5.49</td><td align="center">0.01</td><td align="center">0.3</td><td align="center">&#x02013;0.13</td><td align="center">75.11</td></tr><tr><td align="left"><italic>o</italic>-Cymene</td><td align="center">219.4</td><td align="center">&#x02013;4.99</td><td align="center">&#x02013;0.5</td><td align="center">&#x02013;5.29</td><td align="center">&#x02013;5.29</td><td align="center">0.0</td><td align="center">0.3</td><td align="center">&#x02013;0.2</td><td align="center">74.42</td></tr><tr><td align="left">Alpha-pinene</td><td align="center">77.63</td><td align="center">&#x02013;5.61</td><td align="center">&#x02013;0.56</td><td align="center">&#x02013;5.61</td><td align="center">&#x02013;5.61</td><td align="center">0.01</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">71.1</td></tr><tr><td align="left">3-Carene</td><td align="center">103.88</td><td align="center">&#x02013;5.43</td><td align="center">&#x02013;0.54</td><td align="center">&#x02013;5.43</td><td align="center">&#x02013;5.44</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">0.0</td><td align="center">74.49</td></tr></tbody></table><table-wrap-foot><fn><p>All energy values are given in Kcal/mol.</p></fn></table-wrap-foot></table-wrap><fig id="fig0020"><label>Fig. 4</label><caption><p>Alpha-terpineol (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sites ofamino acid residues represented in red colour line model; (c) hydrogen bond (green dotted lines represents), hydrophobic interactions (alkyl and pi-alkyl are shown in light pink colour dotted lines; pi-sigma interactions are shown in dark purple), and van der Waals interactions (light green colour circles). Solvent accessible surfaces of the interacting residues are represented by a blue halo around the residues.</p></caption><alt-text id="at0020">Fig. 4</alt-text><graphic xlink:href="gr4_lrg"/></fig><fig id="fig0025"><label>Fig. 5</label><caption><p><sc>d</sc>-Limonene (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sitesof amino acid residues represented in red colour line model; (C) hydrophobic interactions (alkyl are shown in light pink colour dotted lines), van der Waals interactions (light green colour circles).</p></caption><alt-text id="at0025">Fig. 5</alt-text><graphic xlink:href="gr5_lrg"/></fig><fig id="fig0030"><label>Fig. 6</label><caption><p><italic>o</italic>-Cymene (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sites ofamino acid residues represented in red colour line model; (C) hydrophobic interactions (alkyl and pi-alkyl are shown in light pink colour dotted lines; amide-pi stacked interaction are shown in dark pink colour), van der Waals interactions (light green colour circles). Solvent accessible surfaces of the interacting residues are represented by a blue halo around the residues.</p></caption><alt-text id="at0030">Fig. 6</alt-text><graphic xlink:href="gr6_lrg"/></fig><fig id="fig0035"><label>Fig. 7</label><caption><p>Alpha-pinene (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sites of amino acid residues represented in red colour line model; (c) hydrophobic interactions (alkyl are shown in light pink colour dotted lines), van der Waals interactions (light green colour circles). Solvent accessible surfaces of the interacting residues are represented by a blue halo around the residues.</p></caption><alt-text id="at0035">Fig. 7</alt-text><graphic xlink:href="gr7_lrg"/></fig><fig id="fig0040"><label>Fig. 8</label><caption><p>3-Carene (violet colour ball and stick model) interactions with M<sup>Pro</sup> represented in (A) solid ribbon model with; (B) active sites of amino acid residues represented in red colour line model; (c) hydrophobic interactions (alkyl and pi-alkyl are shown in light pink colour dotted lines), van der Waals interactions (light green colour circles). Solvent accessible surfaces of the interacting residues are represented by a blue halo around the residues.</p></caption><alt-text id="at0040">Fig. 8</alt-text><graphic xlink:href="gr8_lrg"/></fig></p></sec></sec><sec id="sec0085"><title>Discussion</title><p id="par0095">Corona viruses have been included under the set of RNA viruses which infect humans as well as some animals, and the recent outbreak of Coronavirus has been induced by beta-coronavirus. The liver, respiratory, digestive, and mostly the focal sensory systems of humans and animals are the infection sites affected due to COVID-19 [<xref rid="bib0075" ref-type="bibr">15</xref>]. The prime objective for the progress of effective antiviral agents is SARS coronavirus main peptidase (SARS-CoV M<sup>pro</sup>) which has a major role in virus as it supports its life cycle in case of COVID-19 infection. The Mpro is been considered as the important and significant protein and also an imperative part which brings about the proteolytic development of the infective virus and also it checks the expanded multiplication of contamination by repressing the cleavage of the viral polyprotein [<xref rid="bib0135" ref-type="bibr">27</xref>]. The finding of the structure of M<sup>pro</sup> has provided a major opening to recognize and identify the potent drug against COVID-19. Hence the following study has aimed the main proteases in Coronavirus (3CL<sup>pro</sup>/M<sup>pro</sup>) specifically PDB ID 6LU7, as important target proteins for COVID-19 management and treatment. Herbal medicines are been used worldwide for the curing of wide range of diseases either by consuming it or by taking it in the form of drugs. Several essential oil compounds obtained from plant parts have reported to show anti-viral activities [<xref rid="bib0070" ref-type="bibr">14</xref>]. The inhibitory mechanism of <italic>Eucalyptus</italic> essential oil has been found to be dependent on the blockage activity of the influenza virus by suppressing the main external proteins. [<xref rid="bib0140" ref-type="bibr">28</xref>]. Among seven compounds taken for the study, six compounds eucalyptol, alpha-pinene, alpha-terpineol, 3-carene, <sc>d</sc>-limonene, <italic>o</italic>-cymene present in both <italic>E. globulus</italic> and <italic>C. citrodora</italic> in different compositions. The compound eucalyptol found as a major compound in <italic>E. globulus</italic> (52.47%), whereas in <italic>C. citrodora</italic> composition was found as 13.54%. The compound citronellol was major component (59.31%) present in <italic>C. citrodora.</italic> Eucalyptol along with other compounds like alpha-terpinene, gamma-terpinene, alpha-pinene, <italic>p</italic>-cymene, terpinen-4-ol, alpha-terpineol, thymol, citral obtained from essential oils have shown good potential against (HSV-1) herpes simplex virus type 1 in vitro research, but among all the compounds &#x003b1;-pinene and &#x003b1;-terpineol were slightly superior in their anti-viral activity [<xref rid="bib0145" ref-type="bibr">29</xref>].</p><p id="par0100">The molecular properties including bioavailability and membrane permeability have been linked with many fundamental molecular descriptors like logP (partition coefficient), molecular weight (MW), or number of hydrogen bond acceptors and donors in a molecule. The &#x0201c;rule of five&#x0201d; has been formulated by using these molecular properties [<xref rid="bib0150" ref-type="bibr">30</xref>]. It shows that the majority molecules having fine membrane permeability have molecular weight less than or equal to 500, calculated octanol&#x02013;water partition coefficient, log <italic>P</italic> &#x02264; 5, hydrogen bond donors less than or equal to 5, and acceptors less than or equal to 10 [<xref rid="bib0155" ref-type="bibr">31</xref>]. Hence, Lipinski&#x02019;s Rule of Five has been used to predict and test the biological availability of properties like absorption, distribution, metabolism, and elimination (ADME) of the main compounds. In the following research work, citronellol, alpha-terpineol, <italic>o</italic>-cymene, <sc>d</sc>-limonene, eucalyptol, alpha-pinene, and 3-carene obeyed the Lipinski&#x02019;s rule of five, as well as the compound possess properties of drug likeliness.</p><p id="par0105">Caco-2 cells are made up from human colon adenocarcinoma and contain various numbers of drug transport pathways along with the intestinal epithelium. The predicted Caco-2 values of the compounds shown compounds have moderate intestinal epithelium absorption [<xref rid="bib0160" ref-type="bibr">32</xref>]. HIA information is the expansion of bioavailability and amalgamation assessed from the proportion of discharge or aggregate discharge in urine, bile, and defecation products [<xref rid="bib0165" ref-type="bibr">33</xref>]. In the following study, the calculated HIA of all compounds was shown to be 100%, which suggests that the compounds can get properly absorbed through the intestinal cell [<xref rid="bib0170" ref-type="bibr">34</xref>]. PPB predicts the unbound amount of drugs that help in the inhibition of drug metabolizing transporters and enzymes, which potentially and specifically precipitate an unfavourable reaction [<xref rid="bib0175" ref-type="bibr">35</xref>]. Mostly the strongly bound chemicals are classified as the compounds with more than 90% of PPB while the weakly bound chemicals are classified as the compound with less than 90% of PPB (<ext-link ext-link-type="uri" xlink:href="https://preadmet.bmdrc.kr/adme-prediction/" id="intr0005">https://preadmet.bmdrc.kr/adme-prediction/</ext-link>). The systematic circulation will have less free form of compounds because the predicted value of PPB indicating that all compounds are strongly bound to chemicals except cymene which is moderately bound to chemical. The BBB penetration term finds out whether compounds can move across the blood&#x02013;brain barrier. Based on the C<sub>brain</sub>/C<sub>blood</sub>ratio, all chemicals are categorized within three sections &#x02013; elevated absorption to CNS where C<sub>brain</sub>/C<sub>blood</sub>value will be more than 2.0, medium absorption to CNS where C<sub>brain</sub>/C<sub>blood</sub> value is within 2.0&#x02013;0.1, and low absorption to CNS where C<sub>brain</sub>/C<sub>blood</sub> ratio value will be below 0.1 [<xref rid="bib0180" ref-type="bibr">36</xref>]. The following values are vital in the pharmaceutical sphere because CNS-active compounds should bypass through it and inactive CNS compounds should not surpass across it in order to evade off the side effects of CNS. Except eucalyptol, all the compounds value &#x0003e;2.0 is showing high absorption to CNSP-glycoprotein (P<sub>gp</sub>) which is due to result of the multi drug resistance (MDR) gene alongwith an ATP-dependent efflux transporter which affects the assimilation, allocation and emission of medically significant drugs [<xref rid="bib0185" ref-type="bibr">37</xref>]. The most important factor of drug discovery is to identify molecules that interact with P<sub>gp</sub> transporters, but it is usually confirmed by arduous <italic>in vitro</italic> and <italic>in vivo</italic> studies. However, to predict the likeliness to be substrate for P<sub>gp</sub> and the examining of molecules, it can be done through computational classification [<xref rid="bib0190" ref-type="bibr">38</xref>]. From the following study, alpha-terpineol, limonene, and alpha-pinene were found to inhibit P<sub>gp.</sub> Cytochrome P450 (CYP) which was brought out by the administered drugs that can direct to unwanted effects involved with increase in plasma concentrations or considerable in efficiency of drug [<xref rid="bib0195" ref-type="bibr">39</xref>]. All compounds found to be an inhibitor of CYP_2C9 and non-inhibitor of CYP_2D6. <italic>O</italic>-Cymene and eucalyptol inhibits CYP_3A4, whereas other compounds fond to be a non-inhibitor. The carcinogenicity of the compounds were evaluated and determined by PreADMET server (<ext-link ext-link-type="uri" xlink:href="https://preadmet.bmdrc.kr/" id="intr0010">https://preadmet.bmdrc.kr/</ext-link>). From the AMES test, all the seven compounds were found to be mutagen and eucalyptol was found to be non-carcinogenic in rat and mouse models. The toxicity hazard and the bioavailability of citronellol, alpha-terpineol, eucalyptol, <sc>d</sc>-limonene, 3-carene, <italic>o</italic>-cymene, and alpha-pinene were predicted based on their ADMET profile. The compound eucalyptol possesses good bioavailability, BBB penetration, and inhibitor of CYP_2C9 and CYP_3A4 and non-carcinogenic in rat and mouse models which the major constituent in the leaves of <italic>E. globulus</italic> essential oil.</p><p id="par0110">The inhibition of targeted and main enzyme is caused by knowing the binding affinity and bond formation (hydrogen and hydrophobic) of the most potent molecule. From docking analysis, the compound eucalyptol utilizes slightest binding energy of &#x02013;5.86 k calorie/mole with M<sup>pro</sup> than other compounds. The compounds citronellol and alpha-terpineol form two hydrogen bond interactions with GLU166. Hydrophobic amino acids HIS41, MET165, MET49, and PRO52 residues were found to be key residues that aid in the development of hydrophobic interactions with majority of the compounds. The molecular docking study in this paper showed the inhibition capability of compounds from <italic>Eucalyptus</italic> species and ranked by binding energy (&#x00394;G), eucalyptol &#x0003e; alpha-pinene &#x0003e; alpha-terpineol &#x0003e; 3-carene &#x0003e; <sc>d</sc>-limonene &#x0003e; <italic>o</italic>-cymene &#x0003e; citronellol. The results of this study were consistent with that of Belhassan et al. (2020), who performed molecular docking analysis of the SARS-Cov-2 main protease with oseltamivir derivatives. Hence, the volatile compounds against COVID-9 may work as potent inhibitors of the virus replication and transcription process by inhibiting M<sup>pro</sup>, which is a novel CoV enzyme making these compounds as an important drug target and objective for COVID-19 virus [<xref rid="bib0200" ref-type="bibr">40</xref>]. However, more number of experimental works and studies are required to validate the efficiency of these lead molecules present in <italic>E. globulus</italic> and <italic>C. citrodora</italic>.</p></sec><sec id="sec0090"><title>Conclusion</title><p id="par0115">Currently, the search for proper medication and vaccine for COVID-19 is in progress. The use of <italic>Eucalyptus</italic> and <italic>Corymbia</italic> species essential oil and the main compounds such as eucalyptol and citronellol has shown positive antiviral action in various research studies. We utilized the recently published 3D structure of M<sup>pro</sup> structure from SARS-CoV-2 to predict molecular interaction analysis of volatile compounds from <italic>E. globulus</italic> and <italic>C. citrodora</italic> using Autodock 4.2 software. The docking results attributed various kinds of binding interaction of the drug with M<sup>pro</sup> among which some interactions are said to be favourable. Hence, we have suggested that the two species essential oils, and their bioactive compounds mainly eucalyptol may act as possible inhibitor of M<sup>pro</sup>, and also further research is essential to explore the possible uses of the <italic>Eucalyptus</italic> and <italic>Corymbia</italic> essential oils and their compounds.</p></sec><sec id="sec0095"><title>Funding</title><p id="par0120">This work was supported by TNSCSCT/DST, reference number TNSCSCT/DST-PRG/TD-AWE/VR/06/2017/3033. This project was supported by Researchers Supporting Project number (RSP-2020/257) King Saud University, Riyadh, Saudi Arabia. This work was supported by the Soonchunhyang University Research Fund.</p></sec><sec id="sec0100"><title>Competing interests</title><p id="par0125">None declared.</p></sec><sec id="sec0105"><title>Ethical approval</title><p id="par0130">Not required.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Indranil</surname><given-names>C.</given-names></name><name><surname>Prasenjit</surname><given-names>M.</given-names></name></person-group><article-title>COVID-19 outbreak: migration, effects on society, global environment and prevention</article-title><source>Sci Total Environ</source><volume>728</volume><year>2020</year><fpage>138882</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138882</pub-id><pub-id pub-id-type="pmid">32335410</pub-id></element-citation></ref><ref id="bib0010"><label>2</label><element-citation publication-type="book" id="sbref0010"><person-group person-group-type="author"><name><surname>World Health Organization</surname></name></person-group><chapter-title>Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance</chapter-title><year>2020</year></element-citation></ref><ref id="bib0015"><label>3</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Gorbalenya</surname><given-names>A.E.</given-names></name><name><surname>Baker</surname><given-names>S.C.</given-names></name><name><surname>Baric</surname><given-names>R.S.</given-names></name><name><surname>Groot</surname><given-names>R.J.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name><name><surname>Gulyaeva</surname><given-names>A.A.</given-names></name></person-group><article-title>The species severe acute respiratory syndrome-related coronavirus: classifying 2019-n CoV and naming it SARS-CoV-2</article-title><source>Nat Microbiol</source><volume>5</volume><year>2020</year><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">32123347</pub-id></element-citation></ref><ref id="bib0020"><label>4</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Jansi</surname><given-names>R.S.</given-names></name><name><surname>Khusro</surname><given-names>A.</given-names></name><name><surname>Agastian</surname><given-names>P.</given-names></name><name><surname>Alfarhan</surname><given-names>A.</given-names></name><name><surname>Al-Dhabi</surname><given-names>N.A.</given-names></name><name><surname>Arasu</surname><given-names>M.V.</given-names></name></person-group><article-title>Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents</article-title><source>Sci Total Environ</source><volume>759</volume><year>2021</year><fpage>143539</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.143539</pub-id><pub-id pub-id-type="pmid">33234268</pub-id></element-citation></ref><ref id="bib0025"><label>5</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Indu</surname><given-names>Purushothaman</given-names></name><name><surname>Rameshkumar</surname><given-names>MarimuthuRagavan</given-names></name><name><surname>Arunagirinathan</surname><given-names>Narasingam</given-names></name><name><surname>Al-Dhabi</surname><given-names>NaifAbdullah</given-names></name><name><surname>Arasu</surname><given-names>MariadhasValan</given-names></name><name><surname>Ignacimuthu</surname><given-names>Savarimuthu</given-names></name></person-group><article-title>Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: a molecular docking and drug repurposing approach</article-title><source>J Infect Public Health</source><volume>13</volume><issue>12</issue><year>2020</year><fpage>1856</fpage><lpage>1861</lpage><pub-id pub-id-type="pmid">33168456</pub-id></element-citation></ref><ref id="bib0030"><label>6</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.J.</given-names></name></person-group><article-title>Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicine</article-title><source>J Genet Genom</source><volume>47</volume><issue>2</issue><year>2020</year><fpage>119</fpage><lpage>121</lpage></element-citation></ref><ref id="bib0035"><label>7</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Chenguang</surname><given-names>S.</given-names></name><name><surname>Zhaoqin</surname><given-names>W.</given-names></name><name><surname>Fang</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jinxiu</surname><given-names>L.</given-names></name><name><surname>Jing</surname><given-names>Y.</given-names></name></person-group><article-title>Treatment of 5 critically ill patients with COVID-19 with convalescent plasma</article-title><source>J Amer Med Assoc</source><volume>323</volume><issue>16</issue><year>2020</year><fpage>1582</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.4783</pub-id></element-citation></ref><ref id="bib0040"><label>8</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>H.</given-names></name></person-group><article-title>Drug treatment options for the 2019-new coronavirus (2019-nCoV)</article-title><source>Biosci Trends</source><volume>14</volume><issue>1</issue><year>2020</year><fpage>69</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.5582/bst.2020.01020</pub-id><pub-id pub-id-type="pmid">31996494</pub-id></element-citation></ref><ref id="bib0045"><label>9</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Siti</surname><given-names>K.</given-names></name><name><surname>Hendra</surname><given-names>K.</given-names></name><name><surname>Rizki</surname><given-names>A.</given-names></name><name><surname>Suhartati</surname><given-names>S.</given-names></name><name><surname>Soetjipto</surname><given-names>S.</given-names></name></person-group><article-title>Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study</article-title><source>Med Pharmacology, Pharmacology &#x00026; Toxicology</source><year>2020</year><pub-id pub-id-type="doi">10.20944/preprints202003.0226.v1</pub-id></element-citation></ref><ref id="bib0050"><label>10</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Zakaryan</surname><given-names>H.</given-names></name><name><surname>Arabyan</surname><given-names>E.</given-names></name><name><surname>Oo</surname><given-names>A.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Flavonoids: promising natural compounds against viral infections</article-title><source>Arch Virol</source><volume>162</volume><issue>9</issue><year>2017</year><fpage>2539</fpage><lpage>2551</lpage><pub-id pub-id-type="doi">10.1007/s00705-017-3417-y</pub-id><pub-id pub-id-type="pmid">28547385</pub-id></element-citation></ref><ref id="bib0055"><label>11</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Meghana</surname><given-names>K.</given-names></name><name><surname>Smitha</surname><given-names>L.</given-names></name><name><surname>Pooja</surname><given-names>R.</given-names></name><name><surname>Preethi</surname><given-names>T.</given-names></name><name><surname>Suresh</surname><given-names>R.</given-names></name></person-group><article-title>A comparative study to assess the effect of steam inhalation v/s Tulsi leaves inhalation on the sign and symptoms of cold and cough among adult group in selected areas of Pune city</article-title><source>Int J Med Res</source><volume>2</volume><issue>2</issue><year>2017</year><fpage>24</fpage><lpage>26</lpage></element-citation></ref><ref id="bib0060"><label>12</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Harkenthal</surname><given-names>M.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Geiss</surname><given-names>H.K.</given-names></name><name><surname>Saller</surname><given-names>R.</given-names></name></person-group><article-title>Comparative study on the in vitro antibacterial activity of Australian tea tree oil, cajuput oil, niaouli oil, manuka oil, kanuka oil, and <italic>Eucalyptus</italic> oil</article-title><source>Pharmazie</source><volume>54</volume><year>1999</year><fpage>460</fpage><lpage>463</lpage><comment>PMID: 10399193</comment><pub-id pub-id-type="pmid">10399193</pub-id></element-citation></ref><ref id="bib0065"><label>13</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Salari</surname><given-names>M.H.</given-names></name><name><surname>Amine</surname><given-names>G.</given-names></name><name><surname>Shirazi</surname><given-names>M.H.</given-names></name><name><surname>Hafezi</surname><given-names>R.</given-names></name><name><surname>Mohammadypour</surname><given-names>M.</given-names></name></person-group><article-title>Antibacterial effects of <italic>Eucalyptus globulus</italic> leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders</article-title><source>Clin Microbiol Infect</source><volume>12</volume><year>2006</year><fpage>194</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2005.01284.x</pub-id><pub-id pub-id-type="pmid">16441463</pub-id></element-citation></ref><ref id="bib0070"><label>14</label><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Claudio</surname><given-names>C.</given-names></name><name><surname>Anna</surname><given-names>F.</given-names></name><name><surname>Giuliana</surname><given-names>F.</given-names></name><name><surname>Paola</surname><given-names>Q.</given-names></name></person-group><article-title>Effect of <italic>Eucalyptus</italic> essential oil on respiratory bacteria and viruses</article-title><source>Curr Microbiol</source><volume>56</volume><year>2008</year><fpage>89</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s00284-007-9045-0</pub-id><pub-id pub-id-type="pmid">17972131</pub-id></element-citation></ref><ref id="bib0075"><label>15</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Fabio</surname><given-names>A.</given-names></name><name><surname>Cermelli</surname><given-names>C.</given-names></name><name><surname>Fabio</surname><given-names>G.</given-names></name><name><surname>Nicoletti</surname><given-names>P.</given-names></name><name><surname>Quaglio</surname><given-names>P.</given-names></name></person-group><article-title>Screening of the antibacterial effects of a variety of essential oils on microorganisms responsible for respiratory infections</article-title><source>Phytother Res</source><volume>21</volume><year>2007</year><fpage>374</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17326042</pub-id></element-citation></ref><ref id="bib0080"><label>16</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Heshman</surname><given-names>H.A.R.</given-names></name><name><surname>Abdurahman</surname><given-names>H.N.</given-names></name><name><surname>Rosli</surname><given-names>M.Y.</given-names></name></person-group><article-title>Techniques for extraction of essential oils from plants: a review</article-title><source>Aust J Basic Appl Sci</source><volume>10</volume><issue>16</issue><year>2016</year><fpage>117</fpage><lpage>127</lpage></element-citation></ref><ref id="bib0085"><label>17</label><element-citation publication-type="book" id="sbref0085"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>P.M.</given-names></name><name><surname>Harborne</surname><given-names>J.B.</given-names></name></person-group><chapter-title>Plant biochemistry</chapter-title><edition>1st edition</edition><year>1997</year><publisher-name>Academic Press</publisher-name><publisher-loc>London</publisher-loc></element-citation></ref><ref id="bib0090"><label>18</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Derwich</surname><given-names>E.</given-names></name><name><surname>Benziane</surname><given-names>Z.</given-names></name><name><surname>Taouil</surname><given-names>R.</given-names></name></person-group><article-title>GC/MS analysis of volatile compounds of the essential oil of the leaves of <italic>Mentha pulegium</italic> growing in Morocco</article-title><source>Chem Bull "POLITEHNICA" Univ (Timisoara)</source><volume>55</volume><issue>69</issue><year>2010</year></element-citation></ref><ref id="bib0095"><label>19</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Pala Paul</surname><given-names>J.</given-names></name><name><surname>Perez Alonso</surname><given-names>M.J.</given-names></name><name><surname>Velasco Negueruela</surname><given-names>V.</given-names></name><name><surname>Ramos Vazquez</surname><given-names>P.</given-names></name><name><surname>Gomez Contreras</surname><given-names>F.</given-names></name><name><surname>Sanz</surname><given-names>J.</given-names></name></person-group><article-title>Essential oil of <italic>Santolina rosmarinifolia</italic> L. ssp. rosmarinifolia: first isolation of capillene, a diacetylene derivative</article-title><source>Flavour Frag J</source><volume>14</volume><issue>2</issue><year>1999</year><fpage>131</fpage><lpage>134</lpage></element-citation></ref><ref id="bib0100"><label>20</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>H.M.</given-names></name><name><surname>Westbrook</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name><name><surname>Gilliland</surname><given-names>G.</given-names></name><name><surname>Bhat</surname><given-names>T.N.</given-names></name><name><surname>Weissig</surname><given-names>H.</given-names></name></person-group><article-title>The protein data bank</article-title><source>Nucleic Acids Res</source><volume>28</volume><year>2000</year><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">10592235</pub-id></element-citation></ref><ref id="bib0105"><label>21</label><element-citation publication-type="journal" id="sbref0105"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group><article-title>Structure of Mpro from COVID-19 virus and discovery of its inhibitors</article-title><source>Nature</source><volume>582</volume><year>2020</year><fpage>289</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2223-y</pub-id><pub-id pub-id-type="pmid">32272481</pub-id></element-citation></ref><ref id="bib0110"><label>22</label><element-citation publication-type="journal" id="sbref0110"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>O.N.M.</given-names></name><name><surname>Banck</surname><given-names>M.</given-names></name><name><surname>James</surname><given-names>C.A.</given-names></name><name><surname>Morley</surname><given-names>C.</given-names></name><name><surname>Vandermeersch</surname><given-names>T.</given-names></name></person-group><article-title>Open babel: an open chemical toolbox</article-title><source>J Cheminform</source><volume>33</volume><year>2011</year><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id></element-citation></ref><ref id="bib0115"><label>23</label><element-citation publication-type="journal" id="sbref0115"><person-group person-group-type="author"><name><surname>Atilgan</surname><given-names>E.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name></person-group><article-title>Improving protein docking using sustainable genetic algorithms</article-title><source>Int J Comput Inform Syst Ind Manag Appl</source><volume>3</volume><year>2011</year><fpage>248</fpage><lpage>255</lpage></element-citation></ref><ref id="bib0120"><label>24</label><element-citation publication-type="journal" id="sbref0120"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G.M.</given-names></name><name><surname>Ruth</surname><given-names>H.</given-names></name><name><surname>Lindstrom</surname><given-names>W.</given-names></name><name><surname>Belew</surname><given-names>R.K.</given-names></name><name><surname>Goodsell</surname><given-names>D.S.</given-names></name><name><surname>Olson</surname><given-names>A.J.</given-names></name></person-group><article-title>Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</article-title><source>J Comput Chem</source><volume>30</volume><year>2009</year><fpage>2785</fpage><lpage>2791</lpage><pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id><pub-id pub-id-type="pmid">19399780</pub-id></element-citation></ref><ref id="bib0125"><label>25</label><element-citation publication-type="journal" id="sbref0125"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Teng</surname><given-names>T.</given-names></name><name><surname>Abdalla</surname><given-names>A.E.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name></person-group><article-title>Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS Co</article-title><source>Viruses</source><volume>12</volume><issue>2</issue><year>2020</year><fpage>E244</fpage><pub-id pub-id-type="pmid">32098422</pub-id></element-citation></ref><ref id="bib0130"><label>26</label><element-citation publication-type="journal" id="sbref0130"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R.X.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>H.Z.</given-names></name></person-group><article-title>The crystal structure of 2019-nCoV main protease in complex with an inhibitor N3</article-title><source>Nature</source><volume>582</volume><year>2020</year><pub-id pub-id-type="doi">10.2210/pdb6LU7/pdb</pub-id><comment>Available from:</comment><ext-link ext-link-type="uri" xlink:href="http://wwwrcsborg/structure/6LU7" id="intr0015">http://wwwrcsborg/structure/6LU7</ext-link></element-citation></ref><ref id="bib0135"><label>27</label><element-citation publication-type="journal" id="sbref0135"><person-group person-group-type="author"><name><surname>Akram</surname><given-names>A.</given-names></name><name><surname>Jurgen</surname><given-names>R.</given-names></name><name><surname>Paul</surname><given-names>S.</given-names></name></person-group><article-title>Screening for antiviral activities of isolated compounds from essential oils</article-title><source>Evid Based Compl Altern Med</source><year>2011</year><object-id pub-id-type="publisher-id">253643</object-id></element-citation></ref><ref id="bib0140"><label>28</label><element-citation publication-type="journal" id="sbref0140"><person-group person-group-type="author"><name><surname>Panyod</surname><given-names>S.</given-names></name><name><surname>Ho</surname><given-names>C.T.</given-names></name><name><surname>Sheen</surname><given-names>L.Y.</given-names></name></person-group><article-title>Dietary theraphy and herbal medicine for COVID-19 prevention: a review and prespective</article-title><source>J Tradit Complement Med</source><volume>10</volume><issue>4</issue><year>2020</year><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2020.05.004</pub-id><pub-id pub-id-type="pmid">32691006</pub-id></element-citation></ref><ref id="bib0145"><label>29</label><element-citation publication-type="journal" id="sbref0145"><person-group person-group-type="author"><name><surname>Oleg</surname><given-names>V.P.</given-names></name><name><surname>Evgeny</surname><given-names>V.U.</given-names></name><name><surname>Olga</surname><given-names>P.</given-names></name><name><surname>Igor</surname><given-names>E.A.</given-names></name></person-group><article-title>Inactivation of airborne influenza virus by tea tree and <italic>Eucalyptus</italic> oils</article-title><source>Aerosol Sci Technol</source><volume>462</volume><issue>12</issue><year>2012</year><fpage>1295</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1080/02786826.2012.708948</pub-id></element-citation></ref><ref id="bib0150"><label>30</label><element-citation publication-type="journal" id="sbref0150"><person-group person-group-type="author"><name><surname>Lipinski</surname><given-names>C.A.</given-names></name><name><surname>Lombardo</surname><given-names>F.</given-names></name><name><surname>Dominy</surname><given-names>B.W.</given-names></name><name><surname>Feeney</surname><given-names>P.J.</given-names></name></person-group><article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</article-title><source>Adv Drug Deliv Rev</source><volume>46</volume><issue>1&#x02013;3</issue><year>2001</year><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11259830</pub-id></element-citation></ref><ref id="bib0155"><label>31</label><element-citation publication-type="journal" id="sbref0155"><person-group person-group-type="author"><name><surname>Muegge</surname><given-names>I.</given-names></name></person-group><article-title>Selection criteria for drug-like compounds</article-title><source>Med Res Rev</source><volume>23</volume><issue>3</issue><year>2003</year><fpage>302</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1002/med.10041</pub-id><pub-id pub-id-type="pmid">12647312</pub-id></element-citation></ref><ref id="bib0160"><label>32</label><element-citation publication-type="journal" id="sbref0160"><person-group person-group-type="author"><name><surname>Yazdanian</surname><given-names>M.</given-names></name><name><surname>Glynn</surname><given-names>S.L.</given-names></name><name><surname>Wright</surname><given-names>J.L.</given-names></name><name><surname>Hawi</surname><given-names>A.</given-names></name></person-group><article-title>Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds</article-title><source>Pharm Res</source><volume>15</volume><issue>9</issue><year>1998</year><fpage>1490</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1023/a:1011930411574</pub-id><pub-id pub-id-type="pmid">9755906</pub-id></element-citation></ref><ref id="bib0165"><label>33</label><element-citation publication-type="journal" id="sbref0165"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.H.</given-names></name><name><surname>Le</surname><given-names>J.</given-names></name><name><surname>Abraham</surname><given-names>M.H.</given-names></name><name><surname>Eddershaw</surname><given-names>P.J.</given-names></name><name><surname>Luscombe</surname><given-names>C.N.</given-names></name><name><surname>Butina</surname><given-names>D.</given-names></name></person-group><article-title>Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors</article-title><source>J Pharm Sci</source><volume>90</volume><issue>6</issue><year>2001</year><fpage>749</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1002/jps.1031</pub-id><pub-id pub-id-type="pmid">11357178</pub-id></element-citation></ref><ref id="bib0170"><label>34</label><element-citation publication-type="journal" id="sbref0170"><person-group person-group-type="author"><name><surname>Yee</surname><given-names>S.</given-names></name></person-group><article-title>In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man&#x02014;fact or myth</article-title><source>Pharm Res</source><volume>14</volume><issue>6</issue><year>1999</year><fpage>763</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1023/a:1012102522787</pub-id></element-citation></ref><ref id="bib0175"><label>35</label><element-citation publication-type="journal" id="sbref0175"><person-group person-group-type="author"><name><surname>Bohnert</surname><given-names>T.</given-names></name><name><surname>Gan</surname><given-names>L.S.</given-names></name></person-group><article-title>Plasma protein binding: from discovery to development</article-title><source>J Pharm Sci</source><volume>102</volume><issue>9</issue><year>2013</year><fpage>2953</fpage><lpage>2994</lpage><pub-id pub-id-type="pmid">23798314</pub-id></element-citation></ref><ref id="bib0180"><label>36</label><element-citation publication-type="journal" id="sbref0180"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name></person-group><article-title>Predictive model of blood-brain barrier penetration of organic compounds</article-title><source>Acta Pharmacol Sin</source><volume>26</volume><issue>4</issue><year>2005</year><fpage>500</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">15780201</pub-id></element-citation></ref><ref id="bib0185"><label>37</label><element-citation publication-type="journal" id="sbref0185"><person-group person-group-type="author"><name><surname>Schinkel</surname><given-names>A.H.</given-names></name></person-group><article-title><italic>P</italic>-Glycoprotein, a gatekeeper in the blood&#x02013;brain barrier</article-title><source>Adv Drug Deliv Rev</source><volume>36</volume><issue>2</issue><year>1999</year><fpage>179</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/s0169-409x(98)00085-4</pub-id><pub-id pub-id-type="pmid">10837715</pub-id></element-citation></ref><ref id="bib0190"><label>38</label><element-citation publication-type="journal" id="sbref0190"><person-group person-group-type="author"><name><surname>Joung</surname><given-names>J.Y.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Kim</surname><given-names>H.J.M.</given-names></name><name><surname>Ahn</surname><given-names>S.K.</given-names></name><name><surname>Nam</surname><given-names>K.Y.</given-names></name><name><surname>No</surname><given-names>K.T.</given-names></name></person-group><article-title>Prediction models of <italic>p</italic>-glycoprotein substrates using simple 2d and 3d descriptors by a recursive partitioning approach</article-title><source>Bull Korean Chem Soc</source><volume>33</volume><issue>4</issue><year>2012</year><fpage>1123</fpage><lpage>1127</lpage></element-citation></ref><ref id="bib0195"><label>39</label><element-citation publication-type="journal" id="sbref0195"><person-group person-group-type="author"><name><surname>Backman</surname><given-names>J.T.</given-names></name><name><surname>Wang</surname><given-names>J.S.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Kivisto</surname><given-names>K.T.</given-names></name><name><surname>Neuvonen</surname><given-names>P.J.</given-names></name></person-group><article-title>Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam</article-title><source>Clin Pharmacol Ther</source><volume>66</volume><issue>4</issue><year>1999</year><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">10546924</pub-id></element-citation></ref><ref id="bib0200"><label>40</label><element-citation publication-type="journal" id="sbref0200"><person-group person-group-type="author"><name><surname>Belhassan</surname><given-names>A.</given-names></name><name><surname>Chtita</surname><given-names>S.</given-names></name><name><surname>Zaki</surname><given-names>H.</given-names></name><name><surname>Lakhlifi</surname><given-names>T.</given-names></name><name><surname>Bouachrine</surname><given-names>M.</given-names></name></person-group><article-title>Molecular docking analysis of N-substituted oseltamivir derivatives with the SARS-Cov-2 main protease</article-title><source>Bioinformation</source><volume>16</volume><issue>5</issue><year>2020</year><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.6026/97320630016404</pub-id><pub-id pub-id-type="pmid">32831522</pub-id></element-citation></ref><ref id="bib0205"><label>41</label><element-citation publication-type="journal" id="sbref0205"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>R.G.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>A.G.</given-names></name><name><surname>Quintans</surname><given-names>J.S.</given-names></name><name><surname>Santos</surname><given-names>M.R.</given-names></name><name><surname>De Sousa</surname><given-names>D.P.</given-names></name><name><surname>Badaue-Passos</surname><given-names>D.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Citronellol, a monoterpene alcohol, reduces nociceptive and inflammatory activities in rodents</article-title><source>J Nat Med</source><volume>66</volume><issue>October (4)</issue><year>2012</year><fpage>637</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1007/s11418-012-0632-4</pub-id><comment>Epub 2012 February 21. PMID: 22350215</comment><pub-id pub-id-type="pmid">22350215</pub-id></element-citation></ref><ref id="bib0210"><label>42</label><element-citation publication-type="journal" id="sbref0210"><person-group person-group-type="author"><name><surname>Selvarani</surname><given-names>V.</given-names></name><name><surname>James</surname><given-names>H.</given-names></name></person-group><article-title>American anti-influenza virus activity of essential oils and vapors</article-title><source>J Essent Oils Nat Prod</source><volume>2</volume><issue>1</issue><year>2014</year><fpage>47</fpage><lpage>53</lpage></element-citation></ref><ref id="bib0215"><label>43</label><element-citation publication-type="journal" id="sbref0215"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S.N.</given-names></name><name><surname>Lim</surname><given-names>Y.K.</given-names></name><name><surname>Freire</surname><given-names>M.O.</given-names></name><name><surname>Cho</surname><given-names>E.</given-names></name><name><surname>Jin</surname><given-names>D.</given-names></name><name><surname>Kook</surname><given-names>J.K.</given-names></name></person-group><article-title>Antimicrobial effect of linalool and &#x003b1;-terpineol against periodontopathic and cariogenic bacteria</article-title><source>Anaerobe</source><volume>18</volume><issue>June (3)</issue><year>2012</year><fpage>369</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.anaerobe.2012.04.001</pub-id><comment>Epub 2012 April 17. PMID: 22537719</comment><pub-id pub-id-type="pmid">22537719</pub-id></element-citation></ref><ref id="bib0220"><label>44</label><element-citation publication-type="journal" id="sbref0220"><person-group person-group-type="author"><name><surname>Astani</surname><given-names>A.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name></person-group><article-title>Comparative study on the antiviral activity of selected monoterpenes derived from essential oils</article-title><source>Phytother Res</source><volume>24</volume><issue>May (5)</issue><year>2010</year><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1002/ptr.2955</pub-id><comment>PMID: 19653195; PMCID: PMC7167768</comment><pub-id pub-id-type="pmid">19653195</pub-id></element-citation></ref><ref id="bib0225"><label>45</label><element-citation publication-type="journal" id="sbref0225"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Arciola</surname><given-names>C.R.</given-names></name><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Silva</surname><given-names>A.S.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Sokeng</surname><given-names>A.J.T.</given-names></name></person-group><article-title>Update on monoterpenes as antimicrobial agents: a particular focus on <italic>p</italic>-cymene</article-title><source>Materials (Basel)</source><volume>10</volume><issue>8</issue><year>2017</year><fpage>947</fpage><pub-id pub-id-type="doi">10.3390/ma10080947</pub-id><comment>Published 2017 August 15</comment></element-citation></ref><ref id="bib0230"><label>46</label><element-citation publication-type="journal" id="sbref0230"><person-group person-group-type="author"><name><surname>Gavanji</surname><given-names>S.</given-names></name><name><surname>Sayedipour</surname><given-names>S.S.</given-names></name><name><surname>Larki</surname><given-names>B.</given-names></name><name><surname>Bakhtari</surname><given-names>A.</given-names></name></person-group><article-title>Antiviral activity of some plant oils against herpes simplex virus type 1 in vero cell culture</article-title><source>J Acute Med</source><volume>5</volume><year>2015</year><fpage>62</fpage><lpage>68</lpage></element-citation></ref><ref id="bib0235"><label>47</label><element-citation publication-type="journal" id="sbref0235"><person-group person-group-type="author"><name><surname>Astani</surname><given-names>A.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name></person-group><article-title>Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro</article-title><source>Iran J Microbiol</source><volume>6</volume><issue>3</issue><year>2014</year><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">25870747</pub-id></element-citation></ref><ref id="bib0240"><label>48</label><element-citation publication-type="journal" id="sbref0240"><person-group person-group-type="author"><name><surname>Asif</surname><given-names>M.</given-names></name><name><surname>Saleem</surname><given-names>M.</given-names></name><name><surname>Saadullah</surname><given-names>M.</given-names></name><name><surname>Yaseen</surname><given-names>H.S.</given-names></name><name><surname>Zarzour</surname><given-names>R.A.</given-names></name></person-group><article-title>COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties</article-title><source>Inflammopharmacol</source><volume>28</volume><year>2020</year><fpage>1153</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1007/s10787-020-00744-0</pub-id></element-citation></ref><ref id="bib0245"><label>49</label><element-citation publication-type="journal" id="sbref0245"><person-group person-group-type="author"><name><surname>Juergens</surname><given-names>U.R.</given-names></name><name><surname>Dethlefsen</surname><given-names>U.</given-names></name><name><surname>Steinkamp</surname><given-names>G.</given-names></name><name><surname>Gillissen</surname><given-names>A.</given-names></name><name><surname>Repges</surname><given-names>R.</given-names></name><name><surname>Vetter</surname><given-names>H.</given-names></name></person-group><article-title>Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial</article-title><source>Respir Med</source><volume>97</volume><issue>March (3)</issue><year>2003</year><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1053/rmed.2003.1432</pub-id><comment>PMID: 12645832</comment><pub-id pub-id-type="pmid">12645832</pub-id></element-citation></ref><ref id="bib0250"><label>50</label><element-citation publication-type="journal" id="sbref0250"><person-group person-group-type="author"><name><surname>Morcia</surname><given-names>C.</given-names></name><name><surname>Malnati</surname><given-names>M.</given-names></name><name><surname>Terzi</surname><given-names>V.</given-names></name></person-group><article-title>In vitro antifungal activity of terpinen-4-ol, eugenol, carvone, 1,8-cineole (eucalyptol) and thymol against mycotoxigenic plant pathogens</article-title><source>Food Addit Contam A Chem Anal Control Expo Risk Assess</source><volume>29</volume><issue>3</issue><year>2012</year><fpage>415</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1080/19440049.2011.643458</pub-id><comment>Epub 2012 January 19. PMID: 22257275</comment></element-citation></ref></ref-list><ack id="ack0005"><title>Acknowledgements</title><p id="par0135">This work was supported by <funding-source id="gs0005">TNSCSCT/DST</funding-source>, reference number TNSCSCT/DST-PRG/TD-AWE/VR/06/2017/3033. This project was supported by Researchers Supporting Project number (RSP-2020/257) <funding-source id="gs0010"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100002383</institution-id><institution>King Saud University</institution></institution-wrap></funding-source>, Riyadh, Saudi Arabia. This work was supported by the Soonchunhyang University Research Fund.</p></ack></back></article>